Tuberculosis researcher Christopher Vinnard of Rutgers’ Public Health Research Institute is developing a urine test that can pinpoint—easily and resourcefully—the effectiveness of patients’ TB treatment dosages. This new test would be more accessible to clinicians in low-income countries.
Healio.com’s Infectious Disease News spoke with institute director Richard Marlink, MD, who treated some of the first HIV/AIDS patients at St. Vincent’s Hospital in New York and helped establish the first HIV/AIDS clinic in Boston. In this interview marking the 30th anniversary of World AIDS Day, Marlink discusses the likelihood of a cure and vaccine, federal funding, testing among high-risk populations, PrEP, stigma, and medical treatment.
Thomas Sokolowski, director of Rutgers’ Zimmerli Art Museum, reflects on his work during the 1980s as a pioneer in activism through art. Challenging the world to fight the deadly epidemic that was just becoming known as AIDS, he and a small group of friends founded Visual AIDS, organized the first Day Without Art, and made the red ribbon an icon of awareness.
In this episode of Rutgers Around the World, a podcast produced by Rutgers Global, institute director Richard Marlink shines a light on the field of global health by reflecting on his own career path and his work in fighting HIV/AIDS in the United States and abroad.
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected with HIV. The findings were announced at the September 26, 2018, United Nations meeting on TB.
